Search Result "HER1/HER2 inhibition"
Design, Synthesis and Biological Evaluation of Lapatinib Derivatives as HER1/HER2 Inhibitors
Journal: Letters in Drug Design & Discovery
Volume: 12 Issue: 7 Year: 2015 Page: 574-584
Author(s): Aifeng Lyu,Lei Fang,Shaohua Gou,Xia Liu
HER2-targeted Therapeutic Strategies for HER2-positive Metastatic Breast Cancers
Journal: Current Cancer Therapy Reviews
Volume: 10 Issue: 3 Year: 2014 Page: 225-233
Author(s): Teruhiko Fujii,Keisuke Miwa,Tomoyuki Ushijima,Mototsugu Matsunaga,Masaru Fukahori,Kotaro Yuge,Uhi Toh,Nobutaka Iwakuma,Ryuji Takahashi,Hiroki Takahashi,Miki Takenaka,Mai Mishima,Yoshito Akagi,Masayoshi Kage,Shino Nakagawa
Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 14 Issue: 9 Year: 2014 Page: 775-793
Author(s): Deepa Subramaniam,Aiwu R. He,Jimmy Hwang,John Deeken,Michael Pishvaian,Marion L. Hartley,John L. Marshall
Targeting of ErbB1, ErbB2, and their Dual Targeting Using Small Moleculesand Natural Peptides: Blocking EGFR Cell Signaling Pathways inCancer: A Mini-Review
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22 Issue: 22 Year: 2022 Page: 2831-2846
Author(s): Sunil Kumar Patnaik,Akey Krishna Swaroop
Peptides for Dual Targeting of ErbB1 and ErbB2: Blocking EGFR CellSignaling Transduction Pathways for Cancer Chemotherapy
Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-11
Author(s): Sunil Kumar Patnaik,Akey Krishna Swaroop,Moola Joghee Nanjan,Moola Joghee Nanjan Chandrasekar
Development of EGFR Family Small Molecule Inhibitors for Anticancer Intervention: An Overview of Approved Drugs and Clinical Candidates
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 38 Year: 2014 Page: 4374-4404
Author(s): Weiyan Cheng,Yongzhou Hu,Rong Sheng
Inhibition of Receptor Tyrosine Kinases in Combination with Chemotherapy for the Treatment of Breast Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8 Issue: 5 Year: 2008 Page: 481-487
Author(s): S. L. Moulder, B. S. Craft, G. N. Hortobagyi
MEK Inhibition Increases Lapatinib Sensitivity Via Modulation of FOXM1
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 1 Year: 2013 Page: 2486-2499
Author(s): S.S. Gayle, R.C. Castellino, M.C. Buss, R. Nahta
Targeting ErbB Receptors in High-Grade Glioma
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 2468-2487
Author(s): Sabina Berezowska, Jurgen Schlegel
Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 18 Issue: 4 Year: 2018 Page: 306-327
Author(s): Heena Singla,Anjana Munshi,Raja Paramjit Singh Banipal,Vinod Kumar